Amrita Hospital, Kochi will serve as the venue for the Indian Myeloma Congress 2026, which will bring together globally renowned experts in multiple myeloma. Considered one of the most significant haematology conferences that unites emerging global advancements in myeloma research and treatment, the Indian Myeloma Congress will be held from January 9 to 11, 2026.

Fifteen internationally acclaimed faculty members along with leading myeloma specialists from across India will participate in the congress. The event will serve as a knowledge-sharing platform for doctors, researchers, fellows, nurses, and haematology teams.

The congress will present new insights and studies in rapidly evolving areas of myeloma management, including diagnosis, risk stratification, novel therapies, immunotherapy, transplantation, MRD monitoring, supportive care, and survivorship. Discussions on integrating cutting-edge research into practical clinical care are expected to be a highlight.

Delegates will have access to international expert lectures, panel discussions, case-based clinical deliberations, and networking opportunities. This academic gathering is set to play a vital role in elevating myeloma care standards across the country and in shaping future clinical practices.

Registrations for the congress have begun. Organizers encourage all healthcare professionals to take part in this major scientific event.